Prosecution Insights
Prosecution Insights
5 pending office actions • 4 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (40%) |
| Double-patenting + other | 2 (40%) |
| Multi-statute (no §101) | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KUCKLA, ANNA GRACE | 1 | 50.0% | +53.3% |
| CHHAY, BONIRATH | 1 | 100.0% | +0.0% |
| XU, QING | 1 | 50.7% | +54.7% |
| KASSA, TIGABU | 1 | 36.6% | +28.4% |
| PECKHAM, RICHARD GRANT | 1 | 67.2% | +37.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18579158 | USE OF LACTOBACILLUS PARACASEI BACTERIAL STRAINS IN THE TREATMENT OF NEWBORNS | CHHAY, BONIRATH | 2d overdue |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17998534 | COMPOSITION COMPRISING METHYLFOLATE | KASSA, TIGABU | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17342057 | METHODS AND INTERMEDIATES FOR THE PREPARATION OF BILE ACID DERIVATIVES | PECKHAM, RICHARD GRANT | 26d |
| 18493221 | USE OF A COMPOSITION COMPRISING MICROORGANISMS TO INCREASE THE INTESTINAL PRODUCTION OF BUTYRIC ACID, FOLIC ACID OR NIACIN AND/OR DECREASE THE INTESTINAL PRODUCTION OF SUCCINIC ACID | XU, QING | 63d |
| 18800808 | FARNESOID X RECEPTOR MODULATORS | KUCKLA, ANNA GRACE | — |
| 17998534 | COMPOSITION COMPRISING METHYLFOLATE | KASSA, TIGABU | — |
| Art Unit | Apps |
|---|---|
| 1645 | 1 |
| 1656 | 1 |
| 1619 | 1 |
| 1627 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18800808 | FARNESOID X RECEPTOR MODULATORS | KUCKLA, ANNA GRACE | — | §112DP | Non-Final OA | — | Pending | Aug 12, 2024 |
| 18579158 | USE OF LACTOBACILLUS PARACASEI BACTERIAL STRAINS IN THE TREATMENT OF NEWBORNS | CHHAY, BONIRATH | 1645 | §103§112DP | Final Rejection | 2d overdue | Pending | Jan 12, 2024 |
| 18493221 | USE OF A COMPOSITION COMPRISING MICROORGANISMS TO INCREASE THE INTESTINAL PRODUCTION OF BUTYRIC ACID, FOLIC ACID OR NIACIN AND/OR DECREASE THE INTESTINAL PRODUCTION OF SUCCINIC ACID | XU, QING | 1656 | §103 | Final Rejection | 63d | Pending | Oct 24, 2023 |
| 17998534 | COMPOSITION COMPRISING METHYLFOLATE | KASSA, TIGABU | 1619 | §103§112 | Non-Final OA | — | Pending | Nov 11, 2022 |
| 17342057 | METHODS AND INTERMEDIATES FOR THE PREPARATION OF BILE ACID DERIVATIVES | PECKHAM, RICHARD GRANT | 1627 | §103Other | Final Rejection | 26d | Pending | Jun 08, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial